Singapore markets open in 41 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
104.09-0.78 (-0.74%)
At close: 04:00PM EDT
104.00 -0.09 (-0.09%)
After hours: 07:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close104.87
Bid103.98 x 1400
Ask104.39 x 800
Day's range103.94 - 104.80
52-week range89.67 - 121.64
Avg. volume5,770,474
Market cap181.078B
Beta (5Y monthly)0.75
PE ratio (TTM)32.43
EPS (TTM)3.21
Earnings date18 Jul 2024 - 22 Jul 2024
Forward dividend & yield2.20 (2.11%)
Ex-dividend date12 Apr 2024
1y target est126.23
  • Zacks

    Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?

    Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Zacks

    Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

    Recently, users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

  • Reuters

    Drugmaker Abbott India posts Q4 profit rise on higher sales

    Indian drugmaker Abbott India reported a 24% rise in fourth-quarter profit on Thursday, as strong sales outpaced the impact of government pricing caps on certain medicines. Revenues of drugmakers such as Abbott India and GlaxoSmithKline Pharma India, which get most of their business from India, have been impacted after the inclusion of some of their drugs in the government's essential medicines list in September 2022, making them susceptible to price caps. Abbott, which is a unit of U.S. healthcare firm Abbott Laboratories, has been trying to mitigate the impact of pricing curbs by driving up sales and cutting back on expenses.